SEC Comment Letter 0000000000-23-008808 to CASSAVA SCIENCES INC (SAVA) (CIK 0001069530) (SAVA)
CASSAVA SCIENCES INC (SAVA) (CIK 0001069530)
Date: Aug. 14, 2023 · CIK: 0001069530 · Accession: 0000000000-23-008808
AI Filing Summary & Sentiment
File numbers found in text: 000-29959
Letter
United States securities and exchange commission logo August 14, 2023 Eric Schoen Chief Financial Officer Cassava Sciences, Inc. 6801 N. Capital of Texas Highway, Building 1, Suite 300 Austin, TX 78731 Re:Cassava Sciences, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed February 28, 2023 File No. 000-29959 Dear Eric Schoen: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
August 14, 2023
Eric Schoen
Chief Financial Officer
Cassava Sciences, Inc.
6801 N. Capital of Texas Highway, Building 1, Suite 300
Austin, TX 78731
Re:Cassava Sciences, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed February 28, 2023
File No. 000-29959
Dear Eric Schoen:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences